1. Home
  2. CLWT vs LYRA Comparison

CLWT vs LYRA Comparison

Compare CLWT & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • LYRA
  • Stock Information
  • Founded
  • CLWT 1971
  • LYRA 2005
  • Country
  • CLWT Hong Kong
  • LYRA United States
  • Employees
  • CLWT N/A
  • LYRA N/A
  • Industry
  • CLWT Professional and commerical equipment
  • LYRA Medical/Dental Instruments
  • Sector
  • CLWT Consumer Discretionary
  • LYRA Health Care
  • Exchange
  • CLWT Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • CLWT 11.6M
  • LYRA 13.5M
  • IPO Year
  • CLWT 1997
  • LYRA 2020
  • Fundamental
  • Price
  • CLWT $1.32
  • LYRA $0.19
  • Analyst Decision
  • CLWT
  • LYRA Buy
  • Analyst Count
  • CLWT 0
  • LYRA 5
  • Target Price
  • CLWT N/A
  • LYRA $4.50
  • AVG Volume (30 Days)
  • CLWT 7.2K
  • LYRA 1.9M
  • Earning Date
  • CLWT 12-29-2024
  • LYRA 11-12-2024
  • Dividend Yield
  • CLWT 6.06%
  • LYRA N/A
  • EPS Growth
  • CLWT 630.02
  • LYRA N/A
  • EPS
  • CLWT 0.28
  • LYRA N/A
  • Revenue
  • CLWT $17,242,000.00
  • LYRA $1,471,000.00
  • Revenue This Year
  • CLWT N/A
  • LYRA N/A
  • Revenue Next Year
  • CLWT N/A
  • LYRA N/A
  • P/E Ratio
  • CLWT $4.79
  • LYRA N/A
  • Revenue Growth
  • CLWT 6.59
  • LYRA 3.37
  • 52 Week Low
  • CLWT $1.28
  • LYRA $0.16
  • 52 Week High
  • CLWT $1.94
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 33.75
  • LYRA 46.20
  • Support Level
  • CLWT $1.32
  • LYRA $0.18
  • Resistance Level
  • CLWT $1.45
  • LYRA $0.22
  • Average True Range (ATR)
  • CLWT 0.07
  • LYRA 0.02
  • MACD
  • CLWT -0.01
  • LYRA -0.00
  • Stochastic Oscillator
  • CLWT 15.79
  • LYRA 16.31

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: